Studies on the compatibility of HLA-class II alleles in patient couples with severe pre-eclampsia using PCR-RFLP methods

American Journal of Reproductive Immunology

Volumn 60, Issue 1, 2008, Pages 75-84

  Ooki, Izumi ^a   Takakuwa, Koichi ^a   Akashi, Mami ^a   Nonaka, Taro ^a   Yokoo, Tomokazu ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Compatibility; Genotype; Gestational hypertension; HLA class II; PCR RFLP; Pre eclampsia

Indexed keywords

GENOMIC DNA; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC INCOMPATIBILITY; GENOTYPE; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPOUSE;

ADULT; ALLELES; FAMILY CHARACTERISTICS; FEMALE; GENOTYPE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY; SPOUSES;

EID: 45349106465     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00592.x     Document Type: Article

References (30)

1. Redman CW, Sargent IL: The immunology of preeclampsia. In Immunology of Pregnancy, G Chaouat (ed). London, CRC Press, 1993, pp 205-230.
2. Wegmann TG: PlacentaM immunotrophism: maternal T cell enhance placental growth and function. Am J Reprod Immunol Microbiol 1987; 156:67-69.
3. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
4. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
5. Thomson G: HLA diseaMe associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995; 32:183-219.
6. Margulies DH: The major histocompatibility complex. In Fundamental Immunology Fourth Edition, WE Paul (ed). Philadelphia, Lippincott-Raven Publishers, 1999, pp 263-285.
7. Takakuwa K, Arakawa M, Tamura M, Hataya I, Higashino M, Yasuda M, Tanaka K: HLA antigens in patients with severe preeclampsia. J Perinat Med 1997; 25:79-83.
8. Omu AE, Al QF, Bukhadour N: Human leukocyte antigens in pregnant women with pre-eclampsia associated with intrauterine growth retardation and in normal controls. Arch Gynecol Obstet 1998; 261:129-137.
9. Takakuwa K, Honda K, Ishii K, Hataya I, Yasuda M, Tanaka K: Studies on the HLA-DRB1 genotypes in Japanese women with severe pre-eclampsia positive and negative for anticardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method. Hum Reprod 1999; 14:2980-2986.
10. Honda K, Takakuwa K, Hataya I, Yasuda M, Kurabayashi T, Tanaka K: HLA-DQB1 and HLA-DPB1 genotypes in severe preeclampsia. Obstet Gynecol 2000; 96:385-389.
11. de Luca Brunori I, Battini L, Simonelli M, Clemente F, Brunori E, Mariotti ML, Genazzani AR: Increased HLA-DR homozygosity associated with pre-eclampsia. Human Reprod 2000; 15:1807-1812.
12. Simon P, Fauchet R, Pilorge M, Calvez C, Le Fiblec B, Cam G, Ang KS, Genetet B, Cloup B: Association of HLA DR4 with the risk of recurrence of pregnancy hypertension. Kidney Int 1988; 34:s125-s128.
13. Kilpatrick DC, Gibson F, Livingstone J, Liston WA: Pre-eclampsia is associated with HLA-DR sharing between mother and fetus. Tissue Antigens 1990; 35:178-181.
14. Hoff C, Peevy K, Giattina K, Spinnato JA, Peterson RD: Maternal-fetal HLA-DR relationships and pregnancy-induced hypertension. Obstet Gynecol 1992; 80:1007-1012.
15. Schneider K, Knutson F, Tamsen L, Sjoberg O: HLA antigen sharing in preeclampsia. Gynaecol Obstet Invest 1994; 37:87-90.
16. de Luca Brunori I, Battini L, Simonelli M, Brunori E, Valentino V, Curcio M, Mariotti ML, Lapi S, Genazzani AR: HLA-DR in couples associated with preeclampsia: Background and updating by DNA sequencing. J Reprod Immunol 2003; 59:235-243.
17. Davey DA, MacGillivray I: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892-898.
18. Ota M, Seki T, Fukushima K, Tsuji K, Inoko H: HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39:187-202.
19. Nomura N, Ota M, Tsuji K, Inoko H: HLA-DQB1 genotyping by a modiefied PCR-RFLP method combined with group-specific primers. Tissue Antigens 1991; 38:53-59.
20. Ota M, Seki T, Nomura N, Sugimura K, Mizuki N, Fukushima K, Tsuji K, Inoko H: Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991; 38:60-71.
21. Opelz G, Mytilineos J, Scherer S, Dunckley H, Trejaut J, Chapman J, Middleton D, Savage D, Fischer O, Bignon JD, Bensa JC, Albert E, Noreen H: Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991; 338:461-463.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
23. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW: Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157:715-725.
24. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:iX-xiv.
25. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BN: The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol 2000; 40:139-155.
26. Lim KJH, Odukoya OA, Ajjan RA, Li T, Weetman AP, Cooke ID: The role of T-helper cytokines in human reproduction. Fertil Steril 2000; 73:136-142.
27. Chaouat G, Zourbas S, Ostogic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J: A brief review of recent data on some cytokine expression at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53:241-256.
28. Vince GS, Starkey PM, Austgulen R: Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynecol 1995; 102:20-25.
29. Todt JC, Yang Y, Lei J: Effects of tumor necrosis factor alpha on human trophoblast cell adhesion and motility. Am J Reprod Immunol 1996; 36:65-71.
30. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trosdale J, Moffett A: Combination of maternal KIR and fetal HLA-C gene influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965.